ANGELINI, CORRADO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 38.216
AS - Asia 13.556
EU - Europa 9.164
AF - Africa 3.384
SA - Sud America 3.207
OC - Oceania 364
Continente sconosciuto - Info sul continente non disponibili 193
Totale 68.084
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 36.377
SG - Singapore 4.300
HK - Hong Kong 3.183
BR - Brasile 2.096
CN - Cina 1.881
IT - Italia 947
FI - Finlandia 894
VN - Vietnam 815
SE - Svezia 750
DE - Germania 732
FR - Francia 731
RU - Federazione Russa 536
PL - Polonia 519
UA - Ucraina 511
GB - Regno Unito 470
IE - Irlanda 290
NL - Olanda 199
AR - Argentina 189
IN - India 186
AT - Austria 184
TR - Turchia 171
MX - Messico 148
IQ - Iraq 133
EC - Ecuador 127
PE - Perù 126
ES - Italia 125
ZA - Sudafrica 125
BE - Belgio 124
SA - Arabia Saudita 121
ID - Indonesia 119
PY - Paraguay 117
KE - Kenya 116
CO - Colombia 114
CA - Canada 111
KR - Corea 111
AO - Angola 110
MA - Marocco 109
DO - Repubblica Dominicana 107
LB - Libano 106
AZ - Azerbaigian 105
PA - Panama 105
HU - Ungheria 104
JO - Giordania 104
JP - Giappone 104
UZ - Uzbekistan 104
LV - Lettonia 103
SI - Slovenia 103
AL - Albania 102
PH - Filippine 102
CW - ???statistics.table.value.countryCode.CW??? 101
DZ - Algeria 100
GR - Grecia 100
VE - Venezuela 100
EG - Egitto 99
MY - Malesia 99
BA - Bosnia-Erzegovina 98
CZ - Repubblica Ceca 98
MK - Macedonia 98
TN - Tunisia 98
CH - Svizzera 97
HN - Honduras 97
JM - Giamaica 97
KG - Kirghizistan 97
BZ - Belize 96
MU - Mauritius 95
NP - Nepal 95
RS - Serbia 95
GT - Guatemala 94
IL - Israele 94
LA - Repubblica Popolare Democratica del Laos 94
PT - Portogallo 94
RO - Romania 94
ML - Mali 93
AE - Emirati Arabi Uniti 92
CV - Capo Verde 92
KZ - Kazakistan 92
TJ - Tagikistan 92
AM - Armenia 91
IS - Islanda 91
PR - Porto Rico 91
GM - Gambi 90
SK - Slovacchia (Repubblica Slovacca) 90
TZ - Tanzania 90
CR - Costa Rica 89
GF - Guiana Francese 89
LC - Santa Lucia 89
BB - Barbados 88
MG - Madagascar 88
UY - Uruguay 88
DK - Danimarca 87
ME - Montenegro 87
UG - Uganda 87
HR - Croazia 86
NO - Norvegia 86
YT - Mayotte 86
CY - Cipro 85
MR - Mauritania 85
PK - Pakistan 85
ET - Etiopia 84
KH - Cambogia 84
Totale 63.853
Salva come PNG Salva come JPEG
Città #
Fairfield 5.555
Woodbridge 3.255
Hong Kong 3.093
Houston 2.743
Ashburn 2.616
Singapore 2.310
Chandler 2.243
Seattle 2.031
Ann Arbor 1.955
Wilmington 1.861
Cambridge 1.825
Jacksonville 1.825
Princeton 1.059
Boardman 1.052
San Diego 862
Medford 743
Roxbury 618
Santa Clara 542
Des Moines 448
Helsinki 442
Beijing 428
Bytom 398
Dong Ket 342
Guangzhou 290
Nanjing 220
Dublin 167
Menlo Park 166
New York 162
Ho Chi Minh City 160
Padova 153
São Paulo 141
Munich 128
Los Angeles 113
Shanghai 112
Hanoi 105
Vienna 105
Luanda 102
Amman 100
Ogden 100
Baku 99
Nairobi 95
Tashkent 95
Panama City 93
Nuremberg 90
Bamako 89
Bishkek 89
London 89
Norwalk 89
Castries 88
Dushanbe 88
Riga 85
Lima 84
Vientiane 84
Antananarivo 83
Willemstad 82
Bridgetown 81
Hebei 81
Kampala 81
Nouakchott 81
Managua 79
Praia 78
Ulan Bator 78
Conakry 77
Kigali 76
Abidjan 75
Cotonou 74
Dakar 74
Milan 74
Phnom Penh 74
Lusaka 73
Nassau 73
Yerevan 73
Rio de Janeiro 72
San José 71
Shenyang 71
Dar es Salaam 70
Montevideo 70
Accra 69
Kingston 68
Podgorica 68
Djibouti 67
Reykjavik 67
Harare 66
Noumea 66
Havana 63
Libreville 62
Chicago 60
Ljubljana 60
Pristina 60
Tbilisi 60
Mountain View 59
Buffalo 58
Chisinau 58
Guatemala City 58
Kingstown 58
Cayenne 57
Mamoudzou 56
Addis Ababa 55
Hefei 55
Niamey 55
Totale 45.053
Salva come PNG Salva come JPEG
Nome #
Regulation of Endoplasmic Reticulum-Mitochondria contacts by Parkin via Mfn2 250
"Mitochondrial neuropathies": A survey from the large cohort of the Italian Network 245
A novel deletion in the GTPase domain of OPA1 causes defects in mitochondrial morphology and distribution, but not in function. 219
Calpain III mutation analysis of a heterogeneous limb-girdle muscular dystrophy population 218
Improving the knowledge of amyotrophic lateral sclerosis genetics: novel SOD1 and FUS variants. 189
Parkinson-like features in ALS with predominant upper motor neuron involvement 187
Different atrophy-hypertrophy transcription pathways in muscles affected by severe and mild spinal muscular atrophy 184
Comparison of muscle ultrastructure in myasthenia gravis with anti-MuSK and anti-AChR antibodies 181
Primary coenzyme Q10 deficiency presenting as fatal neonatal multiorgan failure. 181
Brain involvement in myotonic dystrophies: neuroimaging and neuropsychological comparative study in DM1 and DM2 181
Cardiomyopathy in patients with POMT1-related congenital and limb-girdle muscular dystrophy. 181
Functional changes in Becker muscular dystrophy: Implications for clinical trials in dystrophinopathies 181
Acute quadriplegic myopathy in a 17 month old boy 178
Progress in enzyme replacement therapy in glycogen storage disease type II 173
ALS risk but not phenotype is affected by ataxin-2 intermediate length polyglutamine expansion 172
Generalized lysosome-associated membrane protein-2 defect explains multisystem clinical involvement and allows leukocyte diagnostic screening in Danon disease 170
Genetic modifiers of Duchenne muscular dystrophy and dilated cardiomyopathy 169
Carnitine and acyltransferase in experimental neurogenic atrophies: changes with treatment 167
Cardioembolic stroke in Danon disease. 166
TGFB2R but not SPP1 genotype modulates osteopontin expression in Duchenne muscular dystrophy muscle. 165
Autophagy dysregulation in Danon disease 164
Abnormal free radical homeostasis and oxphos activity in ALS muscle 163
A study on duplications of the dystrophin gene: Evidence of a geographical difference in the distribution of breakpoints by intron 163
Facioscapulohumeral muscular dystrophy: epidemiological and molecular study in a north-east Italian population sample 162
Hereditary spastic paraplegia associated with peripheral neuropathy: a distinct clinical and genetic entity 161
Study of Muscle Autophagy and Atrophy Markers in Different Phenotypes of Pompe Disease 160
Clinical phenotype, muscle MRI and muscle pathology of LGMD1F 160
The role of botulinum toxin injection and upper esophageal sphincter myotomy in treating oropharyngeal dysphagia 158
Italian validation of INQoL, a quality of life questionnaire for adults with muscle diseases 157
Dominant optic atrophy caused by a novel OPA1 mutation: Disruption of the mitochondrial network with preserved bioenergetics. 157
LGMD2E patients risk developing dilated cardiomyopathy 155
Metabolic myopathies: the challenge of new treatments 155
Aberrant Compartment Formation by HSPB2 Mislocalizes Lamin A and Compromises Nuclear Integrity and Function 155
PREVALENCE OF UNSUSPECTED MYOPATHY IN INFANTS PRESENTING FOR CLUBFOOT SURGERY 154
Heart involvement in muscular dystrophies due to sarcoglycan gene mutations 154
A study on duplications of the dystrophin gene: evidence of a geographical difference in the distribution of breakpoints by intron. 154
The m.3243A>G mitochondrial DNA mutation and related phenotypes. A matter of gender? 153
Activities of mitochondrial complexes correlate with nNOS amount in muscle from ALS patients 153
SPP1 genotype is a determinant of disease severity in Duchenne muscular dystrophy 153
Motor neuron disease in the Padua district of Italy: an epidemiological study 152
Optimization of respiratory chain enzymatic assays in muscle for the diagnosis of mitochondrial disorders. 152
Cognitive profile and MRI findings in limb-girdle muscular dystrophy 2I 152
New motor outcome function measures in evaluation of Late-Onset Pompe disease before and after enzyme replacement therapy 151
MRI in the assessment of muscular pathology: a comparison between limb-girdle muscular dystrophies, hyaline body myopathies and myotonic dystrophies. 150
A mobile app for patients with Pompe disease and its possible clinical applications 149
Heart transplantation in patients with Inherited myopathies associated with end-stage cardiomyopathy: molecular and biochemical defects on cardiac and skeletal muscle 148
Clinical and molecular characterization of limb girdle muscular dystrophy due to LAMA2 mutations. 148
Esophageal motor function in patients with myotonic dystrophy 145
Decreased expression of DMPK: correlation with CTG repeat expansion and fibre type composition in myotonic dystrophy type 1 145
Familial ALS: clinical, genetic and morphological features. 145
The italian limb girdle muscular dystrophy registry: Relative frequency, clinical features, and differential diagnosis 145
Frequency of LGMD gene mutations in Italian patients with distinct clinical phenotypes 145
Radiological evidence of subclinical dysphagia in motor neuron disease 144
Genetic epidemiology of myotonic dystrophy. 144
Therapeutic advances in the management of Pompe disease and other metabolic myopathies 144
Targeted gene panel screening is an effective tool to identify undiagnosed late onset Pompe disease 144
TARDBP (TDP-43) sequence analysis in patients with familial and sporadic ALS: identification of two novel mutations 144
Cardiac involvement in Becker muscular dystrophy 143
Enzyme Replacement Therapy for Pompe Disease 143
MYH7 gene mutation in myosin storage myopathy and scapulo-peroneal myopathy 142
“I have got something positive out of this situation”: psychological benefits of caregiving in relatives of young people with muscular dystrophy 142
Reliability of the North Star Ambulatory Assessment in a multicentric setting 141
Enzyme replacement therapy improves respiratory outcomes in patients with late-onset type II glycogenosis and high ventilator dependency 141
Normal myogenesis and increased apoptosis in myotonic dystrophy type-1 muscle cells. 141
Myoclonus in mitochondrial disorders. 140
Gene expression profiling in dysferlinopathies using a dedicated muscle microarray 139
Exploring mental status in Friedreich's ataxia: a combined neuropsychological, behavioral and neuroimaging study. 138
A pilot trial with clenbuterol in amyotrophic lateral sclerosis 138
Right hemisphere dysfunction and emotional processing in ALS: an fMRI study 138
TNF-α-Induced microRNAs Control Dystrophin Expression in Becker Muscular Dystrophy 137
Comparative transcriptional and biochemical studies in muscle of myotonic dystrophies (DM1 and DM2) 137
Effects of short-to-long term enzyme replacement therapy (ERT) on skeletal muscle tissue in late onset Pompe disease (LOPD). 136
Facioscapulohumeral muscular dystrophy: a multicenter study on hearing function. 136
Clinical and genetic characterization of an Italian family with slow-channel syndrome 135
P. 5.7 Limb-girdle muscular dystrophy type 2E: Clinical, genetic and histopathological features of 27 European patients 134
Hypertrophic cardiomyopathy with mitochondrial myopathy. A new phenotype of complex II defect. 134
Caspase 3 expression correlates with skeletal muscle apoptosis in Duchenne and facio-scapulo human muscular dystrophy. A potential target for pharmacological treatment? 134
Unilateral calf hypertrophy due to S1-radiculopathy 133
Multisystem primary defect of LAMP-2 in Danon disease 133
[An] enumeration shall be made.. 133
Skeletal muscle sarcoplasmic reticulum phenotype in myotonic dystrophy 132
Prevalence of dystrophin-positive fibers in 85 duchenne muscular dystrophy patients 132
Burden, professional support, and social network in families of children and young adults with muscular dystrophies 132
Duchenne phenotype with in-frame deletion removing major portion of dystrophin rod: threshold effect for deletion size? 131
Sphingomonas paucimobilis associated with localised calf myositis 131
Neuropsychological and endocrinological study in myotonic dystrophy type 1 131
Phenotype modulators in myophosphorylase deficiency 131
Cardiac and respiratory involvement in advanced stage Duchenne muscular dystrophy. 131
Clinical expression of facioscapulohumeral muscular dystrophy in carriers of 1-3 D4Z4 reduced alleles: Experience of the FSHD Italian National Registry 131
Epidemiology of ALS in Padova district, Italy, from 1992 to 2005 131
Deflazacort in Duchenne dystrophy: study of long term effect 130
LOPED study: Looking for an early diagnosis in a late-onset Pompe disease high-risk population 130
Tubular aggregates: Sarcoplasmic reticulum origin, calcium storage ability, and functional implications 130
TDP-43 in skeletal muscle of patients affected with amyotrophic lateral sclerosis 129
Human skeletal muscle atrophy in amyotrophic lateral sclerosis reveals a reduction in Akt and an increase in atrogin-1 129
A novel clinical tool to classify facioscapulohumeral muscular dystrophy phenotypes 129
Micro-RNA expression in muscle and fiber morphometry in myotonic dystrophy type 1 129
Cerebellar ataxia and coenzyme Q10 deficiency 128
CAG repeat length in androgen receptor gene is not associated with amyotrophic lateral sclerosis. 128
Spinal and bulbar muscular atrophy: skeletal muscle pathology in male patients and heterozygous females. 128
Totale 15.166
Salva come PNG Salva come JPEG
Categoria #
all - tutte 238.414
article - articoli 206.065
book - libri 170
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 3.502
Totale 448.151
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20219.610 0 0 106 4.390 489 544 93 824 1.258 531 824 551
2021/202211.289 250 1.088 1.015 2.072 498 499 350 1.309 355 179 1.156 2.518
2022/20235.228 1.639 480 68 548 721 634 14 321 530 28 201 44
2023/20242.740 82 291 210 153 131 187 132 121 244 310 418 461
2024/202513.848 28 1.064 764 473 1.634 243 497 1.125 1.710 654 2.239 3.417
2025/202615.407 1.284 5.221 8.902 0 0 0 0 0 0 0 0 0
Totale 69.118